Since 2016, the Stovall Award has honored innovative pioneers in patient-centered care. Below, you’ll find out how each Stovall Award recipient has improved the cancer care system.
Deborah K. Mayer, PhD, RN | 2021 Health Care Provider Award
Read more
Deborah K. Mayer, PhD, RN, AOCN, FAAN
Frances Hill Fox Distinguished Professor
UNC Lineberger Comprehensive Cancer Center
“What I find most impressive about Dr. Mayer is how she marries real-world pragmatism with a deep knowledge of both theory and data. Quite simply, she has impeccable judgment with respect to survivorship program development, training initiatives and policy development. Her career-long involvement in cancer care and contributions to survivorship science and care have left Dr. Mayer with a rich and unique perspective on cancer care in this country and around the world.”
— Donald L. Rosenstein, MD
Director, Comprehensive Cancer Support Program
Division Head, General Adult Psychiatry
University of North Carolina at Chapel Hill
Deborah K. Mayer, PhD, RN, AOCN, FAAN is the Frances Hill Fox Distinguished Professor Emeritus of Nursing at the University of North Carolina Chapel Hill School of Nursing. Dr. Mayer is an advanced practice oncology nurse who has more than 45 years of cancer nursing practice, education, research, and management experience. She earned a PhD from the University of Utah, her MSN from Yale University, her BSN from Excelsior College, her Nurse Practitioner Certificate from the University of Maryland, and her diploma from Pennsylvania Hospital School of Nursing.
Dr. Mayer is past president of the Oncology Nursing Society (ONS), was a member of the National Cancer Institute’s National Cancer Advisory Board (a Presidential appointment) and Board of Scientific Advisors. Dr. Mayer was elected as a fellow of the American Academy of Nursing. She is active in ONS and the American Society of Clinical Oncology (ASCO) and is a Past Chair of the ASCO Survivorship Committee. She served as Editor for the ONS’ Clinical Journal of Oncology Nursing (CJON) from 2007-2015 and has published over 200 articles, book chapters, and editorials on cancer-related issues. She was awarded the ONS Lifetime Achievement Award in 2015 and, in 2016, was appointed as the only nurse to Vice President Biden’s Cancer Moonshot Blue Ribbon Panel. She was the Interim Director of the Office of Cancer Survivorship at NCI from 2018-2020.
At UNC School of Nursing, she was the coordinator for the oncology focus of the adult and gerotonology nurse practitioner program. Her program of research focuses on the issues facing cancer survivors and improving cancer care. She was the Director of Cancer Survivorship at the UNC Lineberger Comprehensive Cancer Center. As a nurse who worked on the “frontline” with cancer survivors, and as a cancer survivor herself, she brings a unique perspective to her clinical, research, and health policy collaborations with the cancer community.
Kimberly D. Richardson | 2021 Patient Advocate Award
Read more
Kimberly D. Richardson
Cancer Survivor, Survivorship Advocate
“Kimberly is a true champion of the patient perspective with a deep understanding of how all stakeholders interact within cancer communities. She approaches her work with a fierce dedication to honor, integrity, and empathy. Her approach to working with all stakeholders is a master class of diplomacy and collaboration. She understands the problems facing the industry and has a creative and tactful way of navigating some of the toughest conversations around access, equity, and equality for cancer care.”
— Alicia C. Staley
VP, Patient Engagement
Medidata
Kimberly D. Richardson is a two-time cancer survivor of both ovarian and breast cancer and has been active as a patient advocate since her first diagnosis in 2013. She was a member of the inaugural group of NCCS Elevate Ambassadors in 2019. As an Elevate Ambassador, she partnered with University of Illinois College of Medicine students to launch an educational program for scientists and cancer survivors called, “Survivors Advising Scientists Educational Program” (SASEP). The mission of SASEP is to create a bidirectional educational platform that connects young investigators with cancer patients, survivors, research advocates and allies to increase scientific literacy and engagement across the community.
Ms. Richardson is a member of several advisory groups on disparities in ovarian and breast cancer, serves on patient expert councils for global organizations striving for better patient outcomes in clinical trials, and advocates at the state and federal level for funding for cancer research. She is the co-Chair of the Patient Advocacy Committee of the Society of Integrative Oncology, where she sits on the Disparities committee. Her most recent appointments are to the NCI Moonshot IMPACT program, the American Board of Emergency Medicine, and the Ovarian Cancer Research Alliance Industry Council on Disparities.
Ms. Richardson is Founder and Organizer of Chicago’s first researcher/survivor summit, including six major teaching hospitals and universities to bring key stakeholders together to discuss current gynecological research. She has written and spoken about her perspective on health inequity related to COVID-19 through blogs, webinars, and podcasts. Prior to her cancer diagnosis, Ms. Richardson had 30 years of urban planning and community economic development experience, serving as the Director of Planning and Development for the City of Harvey, Illinois and managing a community-based non-profit organization.
Julia H. Rowland, PhD | 2020
Read more
Julia H. Rowland, PhD
Smith Center for Healing and the Arts
“Across her career as a clinician, researcher, and teacher in the area of psychosocial aspects of cancer, Dr. Rowland has promoted patient-centeredness, engaged patients, families, and caregivers to inform the process of improving the delivery of quality cancer care and collaborated effectively with others to improve quality within the cancer care system.”
— Deborah K. Mayer, PhD, RN, AOCN, FAAN
Frances Hill Fox Distinguished Professor
Director of Cancer Survivorship
UNC Lineberger Comprehensive Cancer Center
Julia H. Rowland, PhD is a long-time clinician, researcher, and teacher in the area of psychosocial aspects of cancer. She has worked with and conducted competitively funded research among both pediatric and adult cancer survivors, and published broadly in psycho-oncology.
She was recruited to the National Cancer Institute (NCI) to become the first, full-time Director of the Office of Cancer Survivorship (OCS). After 18 years in this role, Dr. Rowland retired from service at the NCI in September 2017 and assumed the role of Senior Strategic Advisor at Smith Center for Healing and the Arts, a small non-profit organization that has been providing integrative support services to cancer patients and their families for over twenty years.
“Dr. Smith provides total and compassionate care to improve the quality of life of all suffering from their illness. He creates a calm environment which is unhurried, allowing the patient to be empowered to have critical conversations. Dr. Smith has taught hundreds how to improve their own skills and thereby the quality of care they deliver.”
— Patrick J. Coyne, MSN, ACHPN, ACNS-BC, FAAN, FPCN
Palliative Care Director
Medical University of South Carolina
Thomas J. Smith, M.D., is a professor of oncology at the Johns Hopkins University School of Medicine, director of Palliative Medicine for Johns Hopkins Medicine and the Harry J. Duffey Family Professor of Palliative Care. He is a medical oncologist and a palliative care specialist with a lifelong interest in better symptom management, communication, and improving access to high quality affordable care. Dr. Smith began Johns Hopkins’ hospital-wide palliative care consult service as well as an inpatient unit, and he is dedicated to accelerating palliative care research and education.
Dr. Smith is also a prostate cancer survivor, experiencing first hand surgery, recurrence, “salvage” radiation therapy and androgen deprivation therapy with many significant side effects. He knows all too well the experience of living and working while waiting for the other shoe to drop.
Harmar Brereton, MD | 2019
Read more
Harmar Brereton, MD
Founder
Northeast Regional Cancer Institute
“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”
—Karen M. Saunders
President, Northeast Regional Cancer Institute
Dr. Brereton is a graduate of Yale University and earned a medical degree from the University of Pittsburgh. Subsequent training in Internal Medicine took him to Emory University in Atlanta, Georgia. Dr. Brereton spent the next six years at the National Cancer Institute doing clinical and basic research and obtained certification in both Medical Oncology and Hematology. He completed additional training at Johns Hopkins for Radiation Oncology and was board certified.
Dr. Brereton served on the staff at Georgetown University for two years and then entered private practice where he spent thirty-three years developing cancer services by founding the Northeast Regional Cancer Institute in his community of Scranton, Pennsylvania. At the end of his private practice career, he was involved in the development of a new school, The Commonwealth Medical College, now the Geisinger Commonwealth School of Medicine, where he continues to serve on the faculty as a Clinical Professor of Medicine. In addition to also teaching at the Weill Cornell School of Medicine, he is also a leadership team member of the International Cancer Expert Corps.
Dana Dornsife | 2019
Read more
Dana Dornsife
Founder and Board Chair
Lazarex Cancer Foundation
“Patient reimbursements and engagement are key, and Ms. Dornsife had the vision to understand that and the leadership to make it happen. Lazarex provides a key to hope…a key to life. I cherish every moment with my grandkids and my daughters, and I get that opportunity because of Dana Dornsife.”
—Jackie Hinckley, Stage 4 Metastatic Breast Cancer Patient
Dana Dornsife is Chair of the Board and Founder of Lazarex Cancer Foundation, a nationwide public non-profit organization she began in 2006. The unique mission of Lazarex is to improve the outcome of cancer care—giving hope, dignity and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement.
Dana has recently expanded the mission at Lazarex to bring transformational change to the bench to bedside process of clinical trial enrollment, retention, minority participation and equitable access with IMPACT (IMproving Patient Access to Cancer Clinical Trials). She is a graduate of Drexel University in Philadelphia and serves as a board member of the USC Brain and Creativity Institute at University of Southern California, the UCSF Cancer Leadership Council, and the MGH Presidents Council.
C. Norman Coleman, MD | 2018
Read more
C. Norman Coleman, MD
Associate Director, Radiation Research Program
Senior Investigator, Radiation Oncology Branch
National Cancer Institute
“Ms. Stovall had a clear and beautiful concept of what needed to be done to improve the quality of cancer care. Much like when Ms. Stovall recognized a problem in need of remedy, Dr. Coleman is a shining example that Ellen’s passion for this goal lives on.”
—Larry Roth
President, International Cancer Expert Corps
Dr. Coleman, a radiation oncologist, is a leading provider advocate for patient-centeredness; emphasizing access to care, respect for patient preferences, and coordination and integration of care.
For more than 45 years, he has provided cancer care and conducted research, including roles as a tenured faculty member in medical and radiation oncology at Stanford, Professor and Chair of Radiation Oncology at Harvard Medical School, and currently Senior Investigator and Associate Director of the Radiation Research Program at the National Cancer Institute (NCI). In recent years, he helped to establish the International Cancer Expert Corps (ICEC), which aims to increase capacity in developing countries to provide high-quality cancer care.
Dr. Coleman graduated from the University of Vermont with a B.A. summa cum laude in mathematics, and from Yale University School of Medicine in 1970. He completed his internship and residency in internal medicine at the University of California, San Francisco, medical oncology at the National Cancer Institute (NCI) and radiation oncology at Stanford. He served in the US Public Health Service (O-4, ret).
Board certified in these three specialties, Dr. Coleman was a tenured faculty member at the Stanford University School of Medicine before joining Harvard Medical School in 1985 as Fuller-American Cancer Society Professor and Chairman, Joint Center for Radiation Therapy.
In 1999, Dr. Coleman returned to the NCI as director of the new Radiation Oncology Sciences Program that he created to coordinate all radiation oncology and related science activities. He served as chief of the Radiation Oncology Branch from 1999–2004 and is now an adjunct member of ROB in the Center for Cancer Research where he has his laboratory currently focusing on radiation-induced molecular- and immunotherapy targets. He serves the NCI as associate director of the Radiation Research Program in the Division of Cancer Treatment and Diagnosis.
Since 2004 Dr. Coleman has also been Senior Medical Advisor in the Office of Emergency Management, Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services. He has written extensively in the fields of radiation modifiers, molecular radiation oncology and, more recently, on health and medical preparedness and planning for radiological or nuclear emergencies, and global health.
Dr. Coleman has been affiliated with NCCS since working with Ellen Stovall on the NCAB/Senate Subcommittee to Evaluate the National Cancer Program in 1993. He helped form the New England Coalition for Cancer Survivorship while at Harvard. He is Senior Scientific Advisor to the International Cancer Expert Corps (ICEC), a non-government organization focusing on global disparities in cancer care.
Dr. Coleman is a Fellow of the American Society of Radiation Oncology, American Society of Clinical Oncology, American College of Radiology and American College of Physicians. Among his awards are the Gold Medal from ASTRO in 2006, the Partnership for Public Service, Samuel J. Heyman Service to America Homeland Security Medal in 2011, the Failla Medal from the Radiation Research Society in 2016 and Doctor of Science (h.c.) from the University of Vermont in 2015.
Gay Crawford | 2018
Read more
Gay Crawford
Founding Director
Cancer CAREpoint
“As founder of Cancer CAREpoint, Gay conducted a community needs assessment over two years where she facilitated focus groups with over 200 community members to develop programs that would serve as the foundation of Cancer CAREpoint.”
—Rob Tufel, MSW, MPH, Executive Director Cancer CAREpoint
For the past 44 years, Gay Crawford has actively counseled thousands of patients and families and played a major leadership role in working toward better and more complete patient-focused cancer care.
She helped found many cancer programs, including: Hospice of the Valley, the second non-profit hospice in California; Courageous Kids, an American Cancer Society program for children with cancer; the California Cancer Registry; the Colon Cancer Free Zone, advocating for colon cancer screening; and was successful in lobbying the insurance industry to get them to pay for breast reconstructions for patients. In 2011 she was invited to serve as the first chair of Stanford’s new South Bay Cancer Center Patient and Family Advisory Council, helping to develop the program and keep the focus on “patient-focused care.”
Gay’s life’s work culminated in 2013 when she founded a Silicon Valley based non-profit organization called Cancer CAREpoint. Cancer CAREpoint has served over four thousand patients and families with a wide-range of free support services. Cancer CAREpoint is the only community-based organization in Silicon Valley providing direct services to anyone impacted by cancer no matter what type of cancer a patient has, where the patient is treated, or ability to pay. Gay succeeded in getting public recognition from all the major medical centers in Silicon Valley about the need for non-medical support for cancer patients and their families.
Gay, who was diagnosed with breast cancer at age 30 and then with lymphoma at age 60, says “I have been able to live long enough to learn how to be of service, to advocate for those who are not able to do so for themselves, to see gaps in health care and to make a difference in bringing programs to those who need them. I am buoyed and blessed by a network of people who have believed that change is possible and have enabled me to make a difference.”
Patrick Coyne, MSN | 2017
Read more
“Pat has been instrumental in advancing concurrent palliative care alongside usual cancer care, especially in the inpatient setting, and in advancing palliative care worldwide. Pat is a nurse first and foremost and has assumed national and international leadership in nursing and in health care in general.”
– Thomas J. Smith, MD
Director of Palliative Care
Johns Hopkins Medicine
Patrick Coyne, an advanced practice nurse, has devoted his career to the advancement of the field of palliative care. Mr. Coyne is the Director of the Palliative Care Program at Medical University of South Carolina (MUSC). He is one of the founders of ELNEC (End-of-Life Nursing Education Consortium), which has educated more than 21,000 nurses in over 90 countries, and he has published over 100 papers on a variety of symptom management and policy issues.
Meg Gaines, JD, LLM | 2017
Read more
“She is an individual who, drawing upon a personal commitment to championing the individual rights of those diagnosed and treated for life-threatening illness, and those of their family members, created an innovative resource that is transforming cancer care daily for scores of patients and families.”
– Julia Rowland, PhD
Former Director,
Office of Cancer Survivorship
National Cancer Institute
Meg Gaines is a lawyer by training, a cancer survivor, and one of the founders of the Center for Patient Partnerships at the University of Wisconsin. The Center trains students in the fields of law, medicine, nursing, pharmacy, and social work to provide advocacy to cancer patients. Interdisciplinary teams help cancer patients understand their diagnoses, get the information necessary to make critical treatment decisions, and support patients’ efforts to get the treatment they need.
Douglas W. Blayney, MD, FACP | 2016
Read more
Douglas W. Blayney, MD, FACP
Douglas W. Blayney, MD, who worked closely with Ellen Stovall, was chosen in 2016 as the inaugural recipient of the Stovall Award. Since 2017, Dr. Blayney has served as the co-chair of the Stovall Award Selection Committee. Read more about Dr. Blayney and the 2016 award below.
NCCS Presents the Inaugural Ellen Stovall Award to Douglas W. Blayney, MD, FACP (Video)
Posted: October 18, 2016
From left to right: Jonathan Stovall, Douglas W. Blayney, and Shelley Fuld Nasso
At the National Coalition for Cancer Survivorship’s (NCCS) 30th Anniversary Reception on October 13, 2016, NCCS presented the inaugural Ellen Stovall Award for Leadership in Patient-Centered Care. The award was created to honor former NCCS CEO Ellen Stovall, who led the organization for more than twenty years and passed away in January 2016 from complications related to her cancer treatments.The award recipient was Douglas W. Blayney, MD, FACP, past president of the American Society of Clinical Oncology (ASCO) and who worked closely with Ellen Stovall for many years. Together they helped initiate the ASCO Quality Symposium, which has become the leading cancer quality meeting in the world.
Shelley Fuld Nasso Remembers Ellen Stovall
NCCS CEO Shelley Fuld Nasso thanked the attendees to the NCCS 30th anniversary reception, many of them current and former NCCS staff and colleagues of Ms. Stovall, for their contributions to the field of cancer survivorship. “Everyone in this room today has helped in some way have an impact on our work over the past 30 years and on the lives of people with cancer,” Ms. Fuld Nasso said.
She continued, “As we commemorate this milestone in our history, we also, of course, have to recognize the devastating loss that we at NCCS felt, and all of us in the cancer community, when Ellen Stovall passed away earlier this year–our former CEO, dear friend, and mentor… Ellen left an indelible mark on all of us… She’s really our guiding light at NCCS and I often find myself thinking, ‘What would Ellen do?’” After a short video tribute to Ellen’s life and advocacy, Shelley invited Ellen Stovall’s son, Jonathan Stovall, on stage to present the award named in his mother’s honor.
Dr. Blayney Accepts the Ellen Stovall Award
In her introduction, Shelley Fuld Nasso highlighted the collaborative efforts of Dr. Blayney and Ms. Stovall. “Dr. Blayney did not shy away from Ellen’s demands that much more needed to be done to ensure access to patient-centered care, or her insistence that patient satisfaction with their cancer care really did matter. Instead, he was a dedicated partner in these efforts.” She continued, “When Ellen and Doug were working shoulder to shoulder on a wide range of cancer quality improvement efforts, they were pioneers. Not all their peers supported, or even saw the point of all their dogged efforts to improve quality.”
Dr. Blayney accepted the inaugural award and honored Ms. Stovall’s work and advocacy for cancer survivors in his remarks. “Ellen was a living reminder of cancer survivorship,” said Dr. Blayney. “She lived her life with purpose and never-failing grace. She articulated for so many audiences, the purpose of our work, and reminded us that it was always about the patient. I am honored with the Stovall award.”
Douglas W. Blayney, MD, FACP is a professor of medicine at the Stanford Comprehensive Cancer Center. His clinical interest is breast cancer, and his operational interests and research focuses on quality improvement in cancer care systems, improvement of the patient experience, and the optimum use of information technology to enhance these missions. He is past president of the American Society of Clinical Oncology (ASCO), and was the founding editor-in-chief of ASCO’s Journal of Oncology Practice.
The Ellen Stovall Award: 2017 and Beyond
At the reception, NCCS announced that beginning in 2017, the Ellen Stovall Award will be an annual, nationwide competition. It will be the first call to action that specifically urges cancer survivors and caregivers to nominate providers who are making dramatic improvements in how they care for cancer patients and their families. With recent changes in care towards value-based reimbursements and the Oncology Care Model, NCCS seeks to highlight providers who are proactively and successfully embracing patient-focused care that is recognized by the very patients they are serving. Dr. Blayney will serve as co-chair of an advisory committee to establish the award’s criteria and evaluate nominations.
Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.
Connect With Us
Harmar Brereton, MD
Founder
Northeast Regional Cancer Institute
“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”
—Karen M. Saunders
President, Northeast Regional Cancer Institute